Kondo Tatsuya, Matsuyoshi Akiko, Matsuyoshi Hidetake, Goto Rieko, Ono Kaoru, Honda Yumi, Iyama Ken-Ichi, Tsuruzoe Kaku, Miyamura Nobuhiro, Araki Eiichi
Kumamoto University, Department of Metabolic Medicine, 1-1-1 Honjo, Kumamoto, Kumamoto, 860-8556, Japan.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1137. Epub 2009 Apr 14.
Primary squamous cell cancer of the thyroid gland (SCT) is a rare malignant tumour and is associated with a high mortality. A female patient who suffered from primary SCT is described in this report. The cancer was identified with acute painful swelling of the thyroid gland, when the patient was under periodical observation for her chronic thyroiditis at our outpatient's clinic. In spite of the highly malignant potential of the cancer as indicated by histological examinations, including p53 and MIB-1 index analyses, the patient has been successfully treated so far with surgery and radiation therapy, surviving for more than 34 months with no sign of recurrence or metastasis. Early diagnosis and prompt treatment might have been essential for the successful management of this patient. Further observations and investigations are necessary to clarify the mechanisms of the long survival and to find a better treatment for the disease.
甲状腺原发性鳞状细胞癌(SCT)是一种罕见的恶性肿瘤,死亡率很高。本报告描述了一名患有原发性SCT的女性患者。该癌症是在患者因慢性甲状腺炎在我们门诊定期观察时,通过甲状腺急性疼痛性肿胀而被发现的。尽管组织学检查(包括p53和MIB-1指数分析)显示该癌症具有高度恶性潜能,但该患者迄今为止已通过手术和放射治疗成功治疗,存活超过34个月,无复发或转移迹象。早期诊断和及时治疗可能是该患者成功治疗的关键。需要进一步观察和研究以阐明长期生存的机制,并找到更好的治疗该疾病的方法。